AIM: To determine the long-term outcomes regarding reinfection with Helicobacter pylori (H. pylori) and endoscopic changes after successful H. pylori eradication. METHODS: From June 1994 to January 2007, 186 patients (M:F = 98:88; mean age 50.0 +/- 11.4 years), in whom H. pylori had been successfully eradicated, were enrolled. The mean duration of follow up was 41.2 +/- 24.0 mo. RESULTS: H. pylori reinfection occurred in 58 patients (31.2%). The average annual reinfection rate was 9.1% per patient year. No recurrence of peptic ulcer was detected at the follow up endoscopy. There were no significant differences between the H. pylori eradication regimens for the reinfection rate and no significant differences in endoscopic findings between the H. pylori-recurred group and the H. pylori-cured group. CONCLUSION: The reinfection rate in Korea is 9.1% which represents a decreasing trend. There was no relationship between H. pylori infection status and changes in endoscopic findings. There was also no recurrence or aggravation of ulcers.
AIM: To determine the long-term outcomes regarding reinfection with Helicobacter pylori (H. pylori) and endoscopic changes after successful H. pylori eradication. METHODS: From June 1994 to January 2007, 186 patients (M:F = 98:88; mean age 50.0 +/- 11.4 years), in whom H. pylori had been successfully eradicated, were enrolled. The mean duration of follow up was 41.2 +/- 24.0 mo. RESULTS:H. pylori reinfection occurred in 58 patients (31.2%). The average annual reinfection rate was 9.1% per patient year. No recurrence of peptic ulcer was detected at the follow up endoscopy. There were no significant differences between the H. pylori eradication regimens for the reinfection rate and no significant differences in endoscopic findings between the H. pylori-recurred group and the H. pylori-cured group. CONCLUSION: The reinfection rate in Korea is 9.1% which represents a decreasing trend. There was no relationship between H. pylori infection status and changes in endoscopic findings. There was also no recurrence or aggravation of ulcers.
Authors: A Rollan; R Giancaspero; F Fuster; C Acevedo; C Figueroa; K Hola; M Schulz; I Duarte Journal: Am J Gastroenterol Date: 2000-01 Impact factor: 10.864
Authors: N Sakaki; T Arakawa; H Katou; K Momma; N Egawa; T Kamisawa; Y Yamada; Y Tu; C Ishikawa; J Ishiwata Journal: J Gastroenterol Date: 1997-02 Impact factor: 7.527
Authors: Giselle Soto; Christian T Bautista; Daniel E Roth; Robert H Gilman; Billie Velapatiño; Masako Ogura; Giedrius Dailide; Manuel Razuri; Rina Meza; Uriel Katz; Thomas P Monath; Douglas E Berg; David N Taylor Journal: J Infect Dis Date: 2003-10-17 Impact factor: 5.226
Authors: M Ito; K Haruma; T Kamada; M Mihara; S Kim; Y Kitadai; M Sumii; S Tanaka; M Yoshihara; K Chayama Journal: Aliment Pharmacol Ther Date: 2002-08 Impact factor: 8.171
Authors: Carolina Porras; Jesse Nodora; Rachael Sexton; Catterina Ferreccio; Silvia Jimenez; Ricardo L Dominguez; Paz Cook; Garnet Anderson; Douglas R Morgan; Laurence H Baker; E Robert Greenberg; Rolando Herrero Journal: Cancer Causes Control Date: 2012-12-12 Impact factor: 2.506
Authors: Stefano Kayali; Marco Manfredi; Federica Gaiani; Laura Bianchi; Barbara Bizzarri; Gioacchino Leandro; Francesco Di Mario; Gian Luigi De' Angelis Journal: Acta Biomed Date: 2018-12-17